Discover
ICU
SeaStar Medical Holding Corporation
4.86
2 x 3.50
2 x 5.84
bid
ask
+
1.19
32.43%
2 @ 05:28 AM
4.72 -0.14 (2.94%)
| Ytd | 102.50% | |
| 1y | 0.21% |
3.70
day range
4.94
2.07
52 week range
12.50
| Open | 3.70 | Prev Close | 3.67 | Low | 3.70 | High | 4.94 | Mkt Cap | 19.43M |
| Vol | 491.28K | Avg Vol | 106.32K | EPS | -2.38 | P/E | N/A | Forward P/E | -0.77 |
| Beta | -1.06 | Short Ratio | 4.33 | Inst. Own | 4.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 3.75 | 200-d Avg | 3.90 | 1yr Est | 7.00 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-13 | 2024-09 | 0 | -1.1 | N/A | N/A |
| 2024-08-13 | 2024-06 | 0 | -1.03 | N/A | N/A |
| 2024-05-14 | 2024-03 | 0 | -4.75 | N/A | N/A |
| 2024-04-16 | 2023-12 | 0 | -4.75 | N/A | N/A |
| 2023-11-14 | 2023-09 | 0 | -3 | N/A | N/A |
| 2023-08-14 | 2023-06 | 0 | -6.25 | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2023-04-20 | Maxim Group | Upgrade | Buy |
Profile
SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-04-11 | BARNETT RICK | Director | 86.66K | Stock Award(Grant) |
| 2023-11-28 | BARON CARYL | Chief Financial Officer | 139.87K | Stock Award(Grant) |
| 2024-11-17 | CHUNG KEVIN | Officer | 13.69K | Purchase |
| 2024-04-11 | COLLINS ALLAN | Director | 54.34K | Stock Award(Grant) |
| 2024-08-29 | GREEN DAVID A | Chief Financial Officer | 10.32K | Stock Award(Grant) |
| 2024-04-11 | LOBO ANDRES | Director | 40.30K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Group Inc | 70.32K | 139.93K | 1.58% |
| 2024-09-29 | Geode Capital Management, LLC | 39.81K | 79.22K | 0.89% |
| 2024-09-29 | Thoroughbred Financial Services LLC | 11.23K | 22.34K | 0.25% |
| 2024-09-29 | Blackrock Inc. | 9.13K | 18.16K | 0.20% |
| 2024-09-29 | PNC Financial Services Group, Inc. | 1.50K | 2.99K | 0.03% |
| 2024-09-29 | Blue Trust, Inc. | 888.00 | 1.77K | 0.02% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Extended Market Index Fund | 41.26K | 82.11K | 0.92% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 27.41K | 54.55K | 0.61% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 23.09K | 45.95K | 0.52% |
| 2024-10-30 | Fidelity Total Market Index Fund | 7.51K | 14.93K | 0.17% |
| 2024-10-30 | Fidelity Series Total Market Index Fund | 5.72K | 11.38K | 0.13% |
| 2024-10-30 | Fidelity NASDAQ Composite Index Fund | 1.42K | 2.83K | 0.03% |
Split
| Split | Date |
|---|---|
| 1 : 10 | 2026-01-05 |
| 1 : 25 | 2024-06-10 |